CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i
Selected adverse events reported after COVID-19 vaccination
-
Sept. 12, 2023
Details:
-
Corporate Authors:
-
Description:Updated Sept. 12, 2023
COVID-19 vaccine recommendations have been updated as of September 12. The content on this page is no longer current and will be updated to align with the new recommendations
At the April 19, 2023 meeting of the Advisory Committee on Immunization Practices, CDC presented data related to further analyses of a preliminary safety signal for persons ages 65 years and older who received the updated (bivalent) Pfizer-BioNTech COVID-19 vaccine in one safety monitoring system, the Vaccine Safety Datalink (VSD). Other safety monitoring systems have not observed similar findings. As time has passed and more safety data have accumulated, the initial finding has decreased, and scientists believe factors other than vaccination might have contributed to the initial finding. The current evidence does not support the existence of a safety issue. FDA and CDC will continue to evaluate data as they are available and update the public as needed.
-
Content Notes:What You Need to Know -- Anaphylaxis after COVID-19 Vaccination -- Reports of Deaths after COVID-19 Vaccination -- Guillain-Barré Syndrome (GBS) after COVID-19 Vaccination -- Myocarditis and Pericarditis after COVID-19 Vaccination -- Thrombosis with Thrombocytopenia Syndrome (TTS) after COVID-19 Vaccination.
-
Subjects:
-
Document Type:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
[PDF-462.95 KB]
